EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Clinical features and outcomes of posterior reversible encephalopathy syndrome after heart transplantation: a case series

Ji Hoon Lim iD, Seok Hyun Kim iD, Cheolyong Mo iD, Hyun-Woo Kim iD, Soo Yong Lee iD

Clinical Transplantation and Research · 2024

DOI: 10.4285/ctr.24.0009 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Transplantation and Research, 2024. Verfasst von Ji Hoon Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National U…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Society for Transplantation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease that may be associated with hypertension, autoregulatory failure, and the use of calcineurin inhibitors following heart transplantation (HT). In this article, we present a case series of PRES, discussing its potential causes and management strategies. Among the 126 HT recipients at our hospital, four were diagnosed with PRES. Three of these patients developed PRES within 7 days after HT. Prior to the onset of PRES, all patients experienced sustained hypertension, and strict blood pressure (BP) control was maintained. Three of the four patients recovered without PRES recurrence, while one patient died of sepsis after an episode of altered consciousness. Hypertension was observed in all patients prior to the onset of PRES, and the majority experienced symptom improvement with BP control. While most cases of PRES were reversible with conservative treatment, including the administration of antiepileptics, one irreversible case resulted in in-hospital mortality. Thus, PRES can have serious outcomes and is not invariably benign.

Schlagwörter

Stichwörter der Autor:innen

Calcineurin inhibitorsCase reportHeart transplantationPosterior reversible encephalopathy syndrome

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medici…
  • Department of Neurology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.

ORCID-Profile: Ji Hoon Lim, Seok Hyun Kim, Cheolyong Mo, Hyun-Woo Kim, Soo Yong Lee

Förderung

  • Korean Society for Transplantation

Zitieren

APA

Lim, J. H., Kim, S. H., Mo, C., Kim, H. W., & Lee, S. Y. (2024). Clinical features and outcomes of posterior reversible encephalopathy syndrome after heart transplantation: a case series. Clinical Transplantation and Research. https://doi.org/10.4285/ctr.24.0009

Vancouver

Lim JH, Kim SH, Mo C, Kim HW, Lee SY. Clinical features and outcomes of posterior reversible encephalopathy syndrome after heart transplantation: a case series. Clinical Transplantation and Research. 2024. doi:10.4285/ctr.24.0009

BibTeX
@article{Lim2024,
  author = {Lim, Ji Hoon and Kim, Seok Hyun and Mo, Cheolyong and Kim, Hyun-Woo and Lee, Soo Yong},
  title = {Clinical features and outcomes of posterior reversible encephalopathy syndrome after heart transplantation: a case series},
  journal = {Clinical Transplantation and Research},
  year = {2024},
  doi = {10.4285/ctr.24.0009}
}
Kostenlos starten →